← Leaderboards
Mark Edward Hatley
St. Jude Children'S Research Hospital
$4,899,188
Attributed
$4,899,188
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $821.2K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,899,188 · 3
By mechanism
R01$4,056,788 · 2
K08$842,400 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Janet Anne Houghton$8,199,871
- Xiang Chen$2,994,809
- Stephen X Skapek$24,951,237
- Jun Yang$3,072,061
- Anand G Patel$290,017
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsGenesMalignant NeoplasmsTumorLaboratoriesInsightCellsMouse ModelChildhood RhabdomyosarcomaPax7 GeneDesignChildPharmacotherapyPax3 GeneGenetically Engineered MouseGene FusionFoxo1a GeneBaseAutomobile DrivingAggressive TherapyClinical TrialsChildhoodExperimental StudyHigh Risk
Grant awards (15)
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$410,606
R01 · FY2025 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$390,077
R01 · FY2024 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$402,394
R01 · FY2023 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$402,394
R01 · FY2022 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$410,606
R01 · FY2021 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2021 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2020 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$398,287
R01 · FY2019 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2018 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2017 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2015 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2014 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2013 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2012 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2011 · CA · contact PI